【摘要】：2015年12月,美國(guó)、歐盟和日本共批準(zhǔn)23個(gè)新藥,包括新分子實(shí)體、新有效成分、新生物制品、新增適應(yīng)證及新劑型藥物。對(duì)全球首次獲得批準(zhǔn)的新分子實(shí)體、新有效成分、新生物制品進(jìn)行分析,重點(diǎn)介紹這些藥物的臨床研究結(jié)果和研發(fā)歷史進(jìn)程。
[Abstract]:In December 2015, the United States, the European Union and Japan approved 23 new drugs, including new molecular entities, new active ingredients, new biological products, new indications and new dosage forms. The new molecular entities, new active components and new biological products approved for the first time in the world were analyzed, and the clinical research results and the research and development history of these drugs were introduced in detail.
【分類號(hào)】：R95
，

本文編號(hào)：2456966